---
title: Effect of Selective Strengthening of Peroneus Longus on Pain , Joint Alignment and Foot Function in Hallux Valgus
nct_id: NCT06541119
overall_status: RECRUITING
phase: NA
sponsor: Cairo University
study_type: INTERVENTIONAL
primary_condition: Hallux Valgus
countries: Egypt
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06541119.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06541119"
ct_last_update_post_date: 2024-08-12
last_seen_at: "2026-05-12T06:30:36.013Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effect of Selective Strengthening of Peroneus Longus on Pain , Joint Alignment and Foot Function in Hallux Valgus

**Official Title:** Effect of Selective Strengthening of Peroneus Longus Muscles on Pain Joint Alignment and Foot Function in Hallux Valgus

**NCT ID:** [NCT06541119](https://clinicaltrials.gov/study/NCT06541119)

## Key Facts

- **Status:** RECRUITING
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 60
- **Lead Sponsor:** Cairo University
- **Conditions:** Hallux Valgus
- **Start Date:** 2024-09-01
- **Completion Date:** 2024-11-15
- **CT.gov Last Update:** 2024-08-12

## Brief Summary

Purpose of this study is to measure Change in Hallux valgus angle (HVA )as measured by kinovea software Change in pain as measured by numerical pain rating scale (NPRS) Change in function as measured by Foot function index (FFI )Egyptian version With the peroneus longus strengthening exercise versus the use of conventional physical therapy programme in cases of hallux valgus patients

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 60 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* All patients must be diagnosed as having mild to moderate Hallux valgus (with Hallux valgus angle between 15-40 degrees)
* patients aging between 18-60 .
* patients must report pain and limited function .
* patients must report that they are not undergoing physiotherapy , not using orthosis , dynamic splinting exercises for Hallux valgus

Exclusion Criteria:

* Patients diagnosed with systematic diseases such as rheumatoid arthritis .
* Cognitive or mental illness.
* Hallux rigidus or limitus .
* History of surgery to foot of Hallux .
* Previous use of foot orthosis .
```

## Arms

- **Selective peroneus longus strengthening exercise** (EXPERIMENTAL) — Group A will receive a weight bearing peroneus longus exercise with conventional physical therapy Programme
- **Conventional physical therapy programme** (ACTIVE_COMPARATOR) — Group B will receive a program consisting of 3 commonly used exercises in Hallux valgus

## Interventions

- **Selective Peroneus longus excercise** (OTHER) — Weight bearing peroneus longus exercise
- **Conventional physical therapy programme** (OTHER) — * Passive abduction of the Hallux with traction
* short foot exercise
* toe spread outs

## Primary Outcomes

- **Hallux valgus angle HVA** _(time frame: Baseline , 6 weeks (after study completion ))_ — Hallux valgus angle will be measures musing kinovea software
- **Level of pain** _(time frame: Baseline , 6 weeks after study completion)_ — Will be measured using numerical pain rating scale Where 0 represents no pain and 10 represents worst pain imaginable
- **Foot function** _(time frame: Baseline , 6 weeks after study completion)_ — Will be measured using Foot Function Index FFI Egyptian version Which is divided into 3 sub categories Pain 0 no pain , 10 worst pain Disability 0 least 10 worst Activity limitation 0 no limitation , 10 worst limitation For the total score, the minimum score is 0% (no pain or difficulty), and maximum score is 100% (worst pain and extreme difficulty requiring assistance).

## Locations (1)

- Cairo university, Giza, Egypt — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.cairo university|giza||egypt` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06541119.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06541119*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*